Arbutus Biopharma Corp - Company Profile
Powered by 
All the sales intelligence you need on Arbutus Biopharma Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Arbutus Biopharma Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Arbutus Biopharma Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Arbutus Biopharma Corp (Arbutus) is a biopharmaceutical company that aims to develop drugs for the treatment of chronic hepatitis B infection (HBV). Patent portfolio, functional cure for chronic HBV, and focus on research and development activities are its key strengths, even as dependence on external collaborations could be a cause for concern for the company. Arbutus could benefit from market position and competitive advantage, regulatory approval and a robust pipeline. However, uncertain R&D outcomes, competition, and reliance on third parties could affect the business prospects of the company shortly.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer